2-Methylimidazole → HCID 71093756, compound
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([N:14]([C:18]([C:20]2[CH:21]=[N:22][C:23](Cl)=[N:24][CH:25]=2)=[O:19])[CH:15]2[CH2:17][CH2:16]2)[CH2:10][CH2:9]1)=O)(C)(C)C.[CH3:27][C:28]1[NH:29][CH:30]=[CH:31][N:32]=1>>[CH:15]1([N:14]([CH:11]2[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]2)[C:18]([C:20]2[CH:25]=[N:24][C:23]([N:29]3[CH:30]=[CH:31][N:32]=[C:28]3[CH3:27])=[N:22][CH:21]=2)=[O:19])[CH2:16][CH2:17]1Participants
3
Procedure
The title compound is prepared from 4-[(2-chloro-pyrimidine-5-carbonyl)-cyclopropyl-amino]-piperidine-1-carboxylic acid tert-butyl ester and 2-methyl-1H-imidazole following procedures analogous to those described in Intermediate 16 and Intermediate 17. LC (method 10): tR=0.56 min; Mass spectrum (ESI+): m/z=327 [M+H]+.
Sources & evidence
- ORD record
- ord-7109d1fa1e604a01b2083c72a5951018
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08921398B2
Reaction notes
Loading…